1
项与 Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences) 相关的临床试验Treatment of Relapsed and/or Refractory CD33-positive Acute Myeloid Leukemia by Infusions of Allogeneic CART-33
The purpose of this study is to evaluate the safety and efficiency of allogeneic cluster of differentiation 33 (CD33)-directed chimeric antigen receptor modified T cells (CART-33) infusions in patients with relapsed / refractory acute myeloid leukemia (AML).
100 项与 Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences) 相关的临床结果
100 项与 Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences) 相关的转化医学
100 项与 Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences) 相关的专利(医药)
100 项与 Anti-CD33 CAR-T(The Affiliated Hospital of the Chinese Academy of Military Medical Sciences) 相关的药物交易